SE442295B - Forfarande for framstellning av 4-amino-5-en-hexansyra - Google Patents

Forfarande for framstellning av 4-amino-5-en-hexansyra

Info

Publication number
SE442295B
SE442295B SE7601205A SE7601205A SE442295B SE 442295 B SE442295 B SE 442295B SE 7601205 A SE7601205 A SE 7601205A SE 7601205 A SE7601205 A SE 7601205A SE 442295 B SE442295 B SE 442295B
Authority
SE
Sweden
Prior art keywords
amino
preparing
procedure
hexanic acid
hexanic
Prior art date
Application number
SE7601205A
Other languages
English (en)
Swedish (sv)
Other versions
SE7601205L (sv
Inventor
B W Metcalf
M Jung
Original Assignee
Merrell Toraude & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Toraude & Co filed Critical Merrell Toraude & Co
Publication of SE7601205L publication Critical patent/SE7601205L/xx
Publication of SE442295B publication Critical patent/SE442295B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7601205A 1975-03-18 1976-02-04 Forfarande for framstellning av 4-amino-5-en-hexansyra SE442295B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/559,544 US3960927A (en) 1975-03-18 1975-03-18 Olefinic derivatives of amino acids

Publications (2)

Publication Number Publication Date
SE7601205L SE7601205L (sv) 1976-09-19
SE442295B true SE442295B (sv) 1985-12-16

Family

ID=24233995

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7601205A SE442295B (sv) 1975-03-18 1976-02-04 Forfarande for framstellning av 4-amino-5-en-hexansyra

Country Status (20)

Country Link
US (1) US3960927A (da)
JP (1) JPS593988B2 (da)
BE (1) BE839657A (da)
CA (1) CA1077487A (da)
CH (1) CH631696A5 (da)
DE (1) DE2607620C2 (da)
DK (1) DK145339C (da)
ES (1) ES445659A1 (da)
FR (1) FR2304329A1 (da)
GB (1) GB1472525A (da)
IE (1) IE42410B1 (da)
IL (1) IL48912A (da)
MX (1) MX4654E (da)
NL (2) NL187161C (da)
NO (1) NO146428C (da)
NZ (1) NZ179834A (da)
PH (1) PH12100A (da)
PT (1) PT64761B (da)
SE (1) SE442295B (da)
ZA (1) ZA76411B (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039549A (en) * 1975-03-18 1977-08-02 Merrell Toraude Et Compagnie Olefinic derivatives of amino acids
US4041041A (en) * 1975-03-18 1977-08-09 Merrell Toraude Et Compagnie Acetylene derivatives of amino acids
US4147873A (en) * 1977-07-01 1979-04-03 Merrell Toraude Et Compagnie α-Vinyl derivatives of α-amino acids
US4139563A (en) * 1977-07-01 1979-02-13 Merrell Toraude Et Compagnie α-ACETYLENIC DERIVATIVES OF AMINES
CA1121375A (en) * 1977-07-01 1982-04-06 Brian W. Metcalf Derivatives of amines and amino acids
CA1157030A (en) * 1977-07-01 1983-11-15 Brian W. Metcalf .alpha.-VINYL AMINO ACIDS
US4326071A (en) * 1977-09-28 1982-04-20 Merrell Toraude Et Compagnie Halomethyl derivatives of gamma-aminobutyric acid and related compounds
US4187316A (en) * 1978-01-12 1980-02-05 Merrell Toraude Et Compagnie Substituted 1,5-cyclohexadiene carboxylic acid derivatives
US4254284A (en) * 1978-01-30 1981-03-03 Merrell Toraude Et Compagnie Process for preparing 4-aminohex-5-ynoic acid
US4178463A (en) * 1978-01-30 1979-12-11 Merrell Toraude Et Compagnie Process for making 4-aminohex-5-enoic acid
US5147868A (en) * 1978-07-24 1992-09-15 Merck & Co., Inc. Thienamycin renal peptidase inhibitors
US4880793A (en) * 1978-07-24 1989-11-14 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
US4323704A (en) * 1979-06-25 1982-04-06 Merrell Toraude Et Compagnie αAcetylene and α-vinyl derivatives of amino acids
US4539208A (en) * 1980-09-17 1985-09-03 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
US4372974A (en) * 1980-06-25 1983-02-08 New York University Anticonvulsive compositions and method of treating convulsive disorders
GB2120244B (en) * 1982-05-17 1985-05-01 Merrell Toraude & Co Aminoalkadiene derivative
GB2133002B (en) * 1982-12-30 1986-01-29 Merrell Toraude & Co Process for preparing 4-amino-5-hexenoic acid
GB8311804D0 (en) * 1983-04-29 1983-06-02 Merrell Toraude & Co Treatment of seizure disorders and pharmaceutical compositions
CA1252477A (en) * 1983-07-07 1989-04-11 Alexander Krantz .gamma.-ALLENYL-.gamma.-AMINOBUTYRIC ACIDS
US4668703A (en) * 1983-07-07 1987-05-26 Syntex (U.S.A.) Inc. γ-allenyl-γ-aminobutyric acids
US4661510A (en) * 1983-08-17 1987-04-28 Syntex (U.S.A.) Inc. α-allenic-α-amino acids as enzyme inhibitors
US4588825A (en) * 1983-10-11 1986-05-13 Merrell Dow Pharmaceuticals Inc. Intermediates for the synthesis of 4-amino-4,5-dihydro-2-furancarboxylic acid
US4632994A (en) * 1983-11-04 1986-12-30 Gruppo Lepetit S.P.A. Process for decomposing N-oxide derivatives producing 5-vinyl-2-pyrrolidones
JPS6137389U (ja) * 1984-08-09 1986-03-08 永大産業株式会社 家具用の戸
DE3536146A1 (de) * 1985-10-10 1987-04-16 Degussa Verfahren zur enantioselektiven herstellung von (alpha)-vinyl-(alpha)-aminocarbonsaeuren
US4806680A (en) * 1986-03-17 1989-02-21 Merck & Co., Inc. 3-halovinylglycine antibacterial agents
US4727062A (en) * 1986-03-17 1988-02-23 Merck & Co., Inc. 3-Halovinylglycine antibacterial agents
CA2028782C (en) * 1989-11-07 2003-10-14 Christian T. Goralski Process for the production of vinyl-gaba
US5208345A (en) * 1990-12-17 1993-05-04 Merrell Dow Pharmaceuticals Inc. Process for the production of (S)-vinyl and allenyl gaba
AU644919B2 (en) * 1990-12-17 1993-12-23 Aventisub Ii Inc. Process for the production of (S)-vinyl and allenyl gaba
EP0546230A1 (en) * 1991-12-10 1993-06-16 Merrell Dow Pharmaceuticals Inc. Novel process for preparing 4-amino-5-hexenoic acid
US5705660A (en) * 1994-08-22 1998-01-06 Board Of Regents, University Of Nebraska-Lincoln Method for the synthesis of α-oxiranyl amino acids
US7098206B2 (en) * 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6998400B2 (en) * 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
AU2349999A (en) 1998-01-29 1999-08-16 Sepracor, Inc. Pharmacological uses of pure (+) -bupropion
AU2483599A (en) 1998-01-29 1999-08-16 Sepracor, Inc. Pharmaceutical uses of optically pure (-)-bupropion
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
US6855820B2 (en) * 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6337328B1 (en) * 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
US6342496B1 (en) 1999-03-01 2002-01-29 Sepracor Inc. Bupropion metabolites and methods of use
CA2430298A1 (en) 2000-11-30 2002-06-06 Banavara Lakshman Mylari Combination of gaba agonists and sorbitol dehydrogenase inhibitors
WO2002043763A2 (en) 2000-11-30 2002-06-06 Pfizer Products Inc. Combination of gaba agonists and aldose reductase inhibitors
CA2525366A1 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
WO2005082372A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. COMBINATION OF γ-AMINOBUTYRIC ACID MODULATORS AND 5-HT 1B RECEPTOR ANTAGONISTS
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
JP2010521453A (ja) * 2007-03-15 2010-06-24 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 新規プロドラッグ
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2537827B1 (en) 2011-06-24 2014-06-11 Targeon SAS Process for preparing 4-amino-5-hexenoic acid from succinimide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2460708A (en) * 1946-03-22 1949-02-01 Merck & Co Inc Process for making acetamido dimethylacrylic acid
US2531595A (en) * 1949-06-09 1950-11-28 Sterling Drug Inc Preparation of alpha-acylamino-alpha-substituted-acetic acids
US2588969A (en) * 1949-11-26 1952-03-11 Eastman Kodak Co Certain acylamino-acrylates and-crotonates as insecticides
US3223729A (en) * 1962-06-06 1965-12-14 Sterling Drug Inc 3-allylhydantoic acid

Also Published As

Publication number Publication date
DE2607620C2 (de) 1984-09-13
MX4654E (es) 1982-07-19
NO146428B (no) 1982-06-21
CA1077487A (en) 1980-05-13
JPS593988B2 (ja) 1984-01-27
PT64761B (en) 1977-06-06
NL187161B (nl) 1991-01-16
BE839657A (fr) 1976-07-16
NZ179834A (en) 1978-06-20
NO760234L (da) 1976-09-21
JPS51125320A (en) 1976-11-01
ES445659A1 (es) 1977-06-01
AU1071676A (en) 1977-08-11
FR2304329B1 (da) 1980-07-18
CH631696A5 (de) 1982-08-31
DK31476A (da) 1976-09-19
SE7601205L (sv) 1976-09-19
IE42410B1 (en) 1980-07-30
US3960927A (en) 1976-06-01
DE2607620A1 (de) 1976-09-30
DK145339C (da) 1983-03-21
FR2304329A1 (fr) 1976-10-15
DK145339B (da) 1982-11-01
IE42410L (en) 1976-09-18
NL930125I1 (nl) 1993-11-01
IL48912A0 (en) 1976-03-31
GB1472525A (en) 1977-05-04
PT64761A (en) 1976-03-01
NL930125I2 (nl) 1997-08-01
NL7601116A (nl) 1976-09-21
NO146428C (no) 1982-09-29
NL187161C (nl) 1991-06-17
ZA76411B (en) 1977-01-26
IL48912A (en) 1980-09-16
PH12100A (en) 1978-11-02

Similar Documents

Publication Publication Date Title
SE442295B (sv) Forfarande for framstellning av 4-amino-5-en-hexansyra
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE420199B (sv) Forfarande for framstellning av 16-oxiderade prostansyraderivat
SE7612365L (sv) L-fenyl-2-oxo-pyrrolidin-4-karbonsyraderivat
SE7608840L (sv) Prostansyraderivat
SE436572B (sv) Forfarande for framstellning av androstadien-17-karbonsyraestrar
SE431652B (sv) Forfarande for framstellning av 7beta-amino-3cefem-3ol-4-karboxylsyraderivat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE416479B (sv) Forfarande for framstellning av hogrena alkolimetallhalogenidkristaller
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE423025B (sv) Forfarande for framstellning av proteinfilameter
NO148487C (no) Fremgangsmaate til fremstilling av svovelsyre
IT1068946B (it) Procedimento per prepararae triemtilidrochinone
RO69281A (ro) Procedeu pentru prepararea alchilamino-s-triazinelor
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
IT1062099B (it) Procedimento per preparare beta-rame-ftalocianina pigmentaria
SE434157B (sv) Forfarande for framstellning av 6-aminopenicillansyra
SE7601566L (sv) Prostansyraderivat
SE427184B (sv) Forfarande for framstellning av 7-aminocefalosporansyraderivat
SE428689B (sv) Forfarande for framstellning av aroyl-fenylnaftalenforeningar
NO142121C (no) Fremgangsmaate til fremstilling av perpropionsyreopploesoninger
SE7607026L (sv) Forfarande for framstellning av 5-alkylpikolinsyra
SE434156B (sv) Forfarande for framstellning av penicilliner
SE414927B (sv) Forfarande for framstellning av 1-metyl-2-(fenyloximetyl)-5-nitroimidazoler
SE415175B (sv) Forfarande for framstellning av klorcyan

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7601205

SPCG Supplementary protection certificate granted

Free format text: 7601205, EXPIRES: 20010204

NAL Patent in force

Ref document number: 7601205-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7601205-3

Format of ref document f/p: F